Many people are more concerned about cost when they see a doctor, no matter what the disease is, because it is a key point in relation to follow-up treatment, and many people abound in giving up treatment because of the high cost. Among my patients, they are also more concerned about the cost of diabetic foot treatment before they come, so today we will take a brief look at the Chinese diabetic foot guidelines on cost. Overall, the cost of treating diabetes and complications is not bad. 2017 global medical costs for diabetes amounted to $727 billion, of which China was $110 billion. In developed countries, the diabetic foot takes up 12-15% of diabetes health care resources, while in developing countries, it is as high as 40%. One third of diabetes healthcare costs in the United States are spent on patients with diabetic foot. Therefore, the diabetic foot generates a huge economic burden on society and families. There are approximately 22.3 million people with diabetes in the U.S., and the 2012 annual diabetes health care spending is $245 billion, of which the per capita cost of diabetic foot is $8658. In addition to the basic diabetes spending, the medical cost of diabetic foot accounts for $9 billion to $13 billion; compared with the control, DFU patients have longer hospital stays, more home health care costs, and twice the medical costs of those with non-foot ulcers , with additional annual per capita medical costs of $11,711 (Medicare card users) and $15,890 (private insurance). The cost of diabetic foot medical care in the UK from 2010 to 2011 was about £580 million, accounting for 0.6% of national health care expenditure. More than half of this cost (£307 million) was spent on DFU care in community and primary care units, £219 million on inpatient DFU costs and £55 million on amputation. Our 2004 multicenter survey showed that the average number of days in hospital for DFU patients was 25 days, with a total average subcost of $14,906; the 2012 multicenter survey again showed higher inpatient costs for DFU patients than in 2004, with higher average daily inpatient costs ($955 vs. $589) but shorter inpatient days [18 (12-32) vs. 21 (15-32) d], after consumer price index correction, the difference in hospitalization costs between the two groups was not statistically significant. Our 2010 multicenter diabetic amputation rate survey illustrated that patients with disease duration greater than 20 years had the longest hospitalization days (42 d) and the highest hospitalization cost (34,253 yuan); with the increase of Wagner classification, the hospitalization cost, however, increased significantly; patients with minor amputations had an average of 3 d less hospitalization time and an average of 10,000 yuan lower hospitalization cost compared with patients with major amputations; secondary or multiple amputations and death Patients not only had significantly longer hospital stays, but also had significantly higher costs. Overall, the average cost of diabetic foot treatment is still quite high, especially for patients with improperly treated amputated limbs. Of course, if people can do a good job of prevention and receive the right treatment in time when problems arise, the cost will be significantly reduced. Therefore, we must learn more about diabetic foot treatment to avoid improper treatment to increase the medical burden.